Biocryst Pharmaceuticals (BCRX)

Add to Watchlists Create an Alert
11.76 -0.41  -3.37% NASDAQ Jul 25, 8:00PM BATS Real time Currency in USD
View Full Chart
BCRX Price Chart
View All Events

BCRX Events

Date Type Description
05/08/2014 Misc Q1 2014 Biocryst Pharmaceuticals Earnings Call
05/02/2014 15:00 EDT Misc Biocryst Announces Nature Publication Demonstrating Efficacy of Bcx4430 in a Non-human Primate Model of Filovirus Infection
05/02/2014 Misc Annual General Meeting for Biocryst Pharmaceuticals Inc
03/03/2014 Earnings Q1 2014 Biocryst Pharmaceuticals Earnings Results. Estimate: -0.11.
02/26/2014 11:00 EDT Misc Q4 2013 Biocryst Pharmaceuticals Earnings Call
02/26/2014 Earnings Q4 2013 Biocryst Pharmaceuticals Earnings Results. Estimate: -0.11.
11/05/2013 11:00 EDT Misc Biocryst Third Quarter 2013 Conference Call
11/05/2013 Earnings Biocryst Pharmaceuticals 3Q13 Reporting. Estimate: -0.13.
08/08/2013 11:00 EDT Misc Biocryst Second Quarter 2013 Conference Call
08/08/2013 Earnings 2Q13 Reporting: Tuesday, August 6, 2013. Estimate: -0.13.
View All Performance Charts

BCRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Biocryst Pharmaceuticals is up 155.1% over the last year vs S&P 500 Total Return up 19.50%, Ohr Pharmaceutical up 2.88%, and Dyax up 116.2%.

Get Quote for
Advertisement

Portfolio Strategies Featuring BCRX

Did Biocryst Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

BCRX Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.biocryst.com
  • IR Website: http://investor.shareholder.com/biocryst/index.cfm
  • HQ Country: United States
  • HQ State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Biocryst Pharmaceuticals Inc. is engaged in the design, optimization and development of novel drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include Peramivir, BCX4161, Forodesine and Ulodesine, among others.

BCRX Excel Add-In Codes

  • Name: =YCI("BCRX","name")
  • Description: =YCI("BCRX","description")
  • Sector: =YCI("BCRX","sector")
  • Industry: =YCI("BCRX","industry")
  • Est. Current Fiscal Year End: =YCI("BCRX","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.